Literature DB >> 28921221

Endocrine responses to total intravenous anesthesia with droperidol, fentanyl, and ketamine in cardiac patients.

Kazuyoshi Hirota1, Shigeharu Wakayama2, Kazuho Sugihara2, Tsuyoshi Kudo1, Tetsuhiro Sakai1, Naoki Kotani1, Hironori Ishihara1, Akitomo Matsuki1.   

Abstract

Ketamine-induced sympathetic stimulation can be inhibited by administration of sedatives such as benzodiazepines, droperidol, or opioids. We have developed total intravenous anesthesia with ketamine in combination with droperidol and fentanyl (DFK) and have used this anesthetic method in more than 4000 surgical cases. In this study, we compared DFK in cardiac surgery with isoflurane-fentanyl anesthesia (AOI-F). Fourteen patients undergoing aortocoronary artery bypass graft surgery were randomly assigned to the DFK or AOI-F groups. The endocrine responses of the patients were evaluated from the plasma, levels of cortisol, antidiuretic hormone (ADH), atrial natriuretic peptide (ANP), and aldosterone. In both groups, anesthesia per se did not induced any significant changes in the hormones. Although cortisol and ADH increased during surgery, ANP and aldosterone did not change appreciably. All hormones were significantly elevated after the end of cardiopulmonary bypass. There were no significant differences in any of the hormones, blood pressure, and heart rate measured at different points in both groups. These results showed that DFK anesthesia as a total intravenous anesthesia deserves to be studied in more depth.

Entities:  

Keywords:  Cardiopulmonary bypass; Endocrine responses; Ketamine; Total intravenous anesthesia

Year:  1995        PMID: 28921221     DOI: 10.1007/BF02479868

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  18 in total

1.  The renin--angiotensin--aldosterone system during cardiac surgery with morphine--nitrous oxide anesthesia.

Authors:  D R Bailey; E D Miller; J A Kaplan; P W Rogers
Journal:  Anesthesiology       Date:  1975-05       Impact factor: 7.892

2.  [Clinical study on total intravenous anesthesia with droperidol, fentanyl and ketamine. 14. Effect on epidural pressure].

Authors:  K Hirota; A Kudo; N Dobashi; Y Shimodate; H Ishihara; A Matsuki
Journal:  Masui       Date:  1992-06

3.  Effects of high-dose fentanyl on fluid and vasopressor requirements after cardiac surgery.

Authors:  K J Tuman; D M Keane; B D Spiess; R J McCarthy; A I Silins; A D Ivankovich
Journal:  J Cardiothorac Anesth       Date:  1988-08

4.  The effect of opioids on rat plasma atrial natriuretic peptide.

Authors:  A M Vollmar; R M Arendt; R Schulz
Journal:  Eur J Pharmacol       Date:  1987-11-17       Impact factor: 4.432

5.  Effects of ketamine on adrenocortical function in man.

Authors:  T Oyama; F Matsumoto; T Kudo
Journal:  Anesth Analg       Date:  1970 Sep-Oct       Impact factor: 5.108

6.  [Effects of isoflurane anesthesia and surgery on plasma concentrations of alpha-hANP and other stress hormones in man].

Authors:  T Iida; T Tsubo; A Matsuki; T Kudou; M Kudou; T Oyama
Journal:  Masui       Date:  1988-02

7.  [Effects of surgical intervention on plasma levels of antidiuretic hormone and alpha-human atrial natriuretic polypeptide under sevoflurane anesthesia].

Authors:  T Murakawa; T Kudo; M Kudo; A Matsuki; T Oyama
Journal:  Masui       Date:  1989-09

8.  [Alpha-atrial natriuretic peptide, antidiuretic hormone and aldosterone levels in patients undergoing aortocoronary grafting under high dose fentanyl anesthesia].

Authors:  Y Takino; Y Sumida; H Hayashi; F Miyagawa
Journal:  Masui       Date:  1990-11

9.  The effect of fentanyl on arginine vasopressin and cortisol secretion during anesthesia.

Authors:  A M Lehtinen; F Fyhrquist; I Kivalo
Journal:  Anesth Analg       Date:  1984-01       Impact factor: 5.108

10.  [Clinical study on total intravenous anesthesia with droperidol, fentanyl and ketamine--7. Effects on natural killer cell activity].

Authors:  H Hashimoto; I Araki; T Sato; A Matsuki
Journal:  Masui       Date:  1991-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.